Vascular endothelial growth factor is bound in amniotic fluid and maternal serum

Abstract

To study vascular endothelial growth factor (VEGF) and placenta growth factor (PlGF) concentrations and their possible binders, serum from 22 non-pregnant and 55 pregnant women (15 at weeks 10-13; 40 at term), umbilical vein (n = 24) and artery (n = 13) and amniotic fluid (a pool of 50 at weeks 15-17; 11 at term) were assessed for VEGF and PlGF by an enzyme-linked immunosorbent assay. In amniotic fluid and maternal serum VEGF concentrations were < 16 ng/ml and added VEGF was not recovered. VEGF was detected in serum from mothers postpartum (137 ± 142 ng/l, mean ± SD), umbilical artery (421 ± 288 ng/l) and vein (502 ± 339 ng/l) and non-pregnant controls (182 ± 147 ng/l), and added VEGF was fully recovered. PlGF was detected in pregnancy serum (52 ± 23 ng/l early pregnancy; 439 ± 217 ng/l term pregnancy) and in amniotic fluid (early pregnancy 56 ng/l; term pregnancy 30 ± 18 ng/l). PlGF was fully recovered in all samples. Gel filtration and isoelectric focusing revealed that in maternal serum and amniotic fluid [125I]VEGF was bound to a protein with an M(r) of 400-700 kDa and an isoelectric point of approximately 8. This protein was not identical with alpha-2-macroglobulin (by an immunofluorometric assay), pregnancy zone protein or pregnancy associated plasma protein-A (by immunodiffusion). In conclusion, VEGF-binding activity is present in amniotic fluid and maternal blood. It disappears after delivery and is not detectable in fetal or non-pregnant serum.